Jane Street’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Jane Street’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-29,186	Closed	-$1.81M	–	10386
2023 Q4	$1.81M	Buy	+29,186	New	+$725K	﹤0.01%	4500

Jane Street's RYZB Position: Q1 2024 in Review

Jane Street sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 29,186 shares — an estimated $1.81M sold.

Jane Street first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $1.81M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Jane Street reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Jane Street sold 29,186 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $1.81M.
Jane Street first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Jane Street's RayzeBio, Inc. Common Stock position peaked at $1.81M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.